ENSYSCE BIOSCIENCES, INC. Current Liabilities
ENSYSCE BIOSCIENCES, INC. (ENSC) had Current Liabilities of $4.07 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-08-13
- 2026-06-30: Liabilities, Current $4.07M.
- 2026-03-31: Liabilities, Current $2.84M.
- 2025-12-31: Liabilities, Current $4.57M.
- 2025-09-30: Liabilities, Current $2.30M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $4.07M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $2.84M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $4.57M 10-Q · filed 2026-08-13 | |
| 2025-09-30 | $2.30M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $2.51M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $1.76M 10-Q · filed 2025-05-13 | |
| 2024-12-31 | $2.21M 10-K · filed 2026-03-30 | |
| 2024-09-30 | $2.80M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $1.31M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $1.64M 10-Q · filed 2024-05-13 | |
| 2023-12-31 | $3.33M 10-K · filed 2025-03-10 | |
| 2023-09-30 | $2.03M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $2.52M 10-Q · filed 2023-08-11 | |
| 2023-03-31 | $3.98M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $9.46M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $11.91M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $8.25M 10-Q · filed 2022-08-11 | |
| 2022-03-31 | $8.80M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | $16.48M 10-K · filed 2023-03-30 | |
| 2021-09-30 | $7.03M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $4.03M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $319.18K 10-Q · filed 2021-06-08 | |
| 2020-12-31 | $7.01M 10-K · filed 2022-03-31 | $260.40K 10-K · filed 2021-03-15 |
| 2020-09-30 | $452.10K 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $793.60K 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $3.49M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $2.77M 10-K/A · filed 2021-06-08 | $2.77M 10-K · filed 2020-03-10 |
| 2019-09-30 | $1.13M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $327.39K 10-Q · filed 2019-08-07 | |
| 2019-03-31 | $387.25K 10-Q · filed 2019-05-07 | |
| 2018-12-31 | $437.89K 10-K · filed 2020-03-10 | |
| 2018-09-30 | $359.15K 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $135.24K 10-Q · filed 2018-08-01 | |
| 2018-03-31 | $197.43K 10-Q · filed 2018-05-03 | |
| 2017-12-31 | $156.24K 10-K/A · filed 2019-03-12 | |
| 2017-09-30 | $380.00K 10-Q · filed 2018-01-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Traws Pharma, Inc. (TRAW) | United States | $0.009B | -0.58 |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |